Factors influencing outcome and treatment effect in PROACT II

Lawrence R. Wechsler, Robin Roberts, Anthony J. Furlan, Randall T. Higashida, William Dillon, Heidi Roberts, Howard A. Rowley, L. Creed Pettigrew, Alfred S. Callahan, Askiel Bruno, Pierre Fayad, Wade S. Smith, Carolyn M. Firszt, Gregory A. Schulz

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Background and Purpose - The PROACT II study demonstrated a significant benefit from treatment with intra-arterial pro-urokinase (r-proUK) in patients with middle cerebral artery occlusion treated within 6 hours of stroke onset. The purpose of the current study was to examine baseline factors to determine predictors of good outcome and response to treatment. Methods - We selected from the baseline clinical, radiologic, and angiographic data variables that considered possibly related to outcome. A univariate analysis was performed to examine the association between these baseline factors and good outcome, defined as a modified Rankin scale score ≤2. A multivariate model then selected the most important variables independently influencing prognosis. A risk score for each patient was constructed on the basis of the patient's individual values for each independent variable. Patients were stratified into risk quartiles based on their risk scores, and an odds ratio for each risk quartile was calculated. The treatment effects of each quartile were compared. Results - In the univariate analysis, screening National Institutes of Health stroke scale (NIHSS) score and age were strongly associated with good outcome. The multivariate model selected age, NIHSS score, and CT hypodensity as the most important prognostic variables. Dividing patients into quartiles based on risk scores achieved a uniform gradient of probability of good outcomes. A trend toward benefit of r-proUK treatment was seen in all risk quartiles, and no differential treatment effect was observed across risk groups. Conclusions - There was no evidence of differential effect of r-proUK across subgroups of patients stratified by risk.

Original languageEnglish (US)
Pages (from-to)1224-1229
Number of pages6
JournalStroke
Volume34
Issue number5
DOIs
StatePublished - May 1 2003
Externally publishedYes

Fingerprint

saruplase
Stroke
National Institutes of Health (U.S.)
Therapeutics
Middle Cerebral Artery Infarction
Odds Ratio

Keywords

  • Outcome
  • Stroke, acute
  • Thrombolytic therapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this

Wechsler, L. R., Roberts, R., Furlan, A. J., Higashida, R. T., Dillon, W., Roberts, H., ... Schulz, G. A. (2003). Factors influencing outcome and treatment effect in PROACT II. Stroke, 34(5), 1224-1229. https://doi.org/10.1161/01.STR.0000068782.15297.28

Factors influencing outcome and treatment effect in PROACT II. / Wechsler, Lawrence R.; Roberts, Robin; Furlan, Anthony J.; Higashida, Randall T.; Dillon, William; Roberts, Heidi; Rowley, Howard A.; Pettigrew, L. Creed; Callahan, Alfred S.; Bruno, Askiel; Fayad, Pierre; Smith, Wade S.; Firszt, Carolyn M.; Schulz, Gregory A.

In: Stroke, Vol. 34, No. 5, 01.05.2003, p. 1224-1229.

Research output: Contribution to journalArticle

Wechsler, LR, Roberts, R, Furlan, AJ, Higashida, RT, Dillon, W, Roberts, H, Rowley, HA, Pettigrew, LC, Callahan, AS, Bruno, A, Fayad, P, Smith, WS, Firszt, CM & Schulz, GA 2003, 'Factors influencing outcome and treatment effect in PROACT II', Stroke, vol. 34, no. 5, pp. 1224-1229. https://doi.org/10.1161/01.STR.0000068782.15297.28
Wechsler LR, Roberts R, Furlan AJ, Higashida RT, Dillon W, Roberts H et al. Factors influencing outcome and treatment effect in PROACT II. Stroke. 2003 May 1;34(5):1224-1229. https://doi.org/10.1161/01.STR.0000068782.15297.28
Wechsler, Lawrence R. ; Roberts, Robin ; Furlan, Anthony J. ; Higashida, Randall T. ; Dillon, William ; Roberts, Heidi ; Rowley, Howard A. ; Pettigrew, L. Creed ; Callahan, Alfred S. ; Bruno, Askiel ; Fayad, Pierre ; Smith, Wade S. ; Firszt, Carolyn M. ; Schulz, Gregory A. / Factors influencing outcome and treatment effect in PROACT II. In: Stroke. 2003 ; Vol. 34, No. 5. pp. 1224-1229.
@article{70d2b8d5f52b4a46b57ba2be2a34dbd2,
title = "Factors influencing outcome and treatment effect in PROACT II",
abstract = "Background and Purpose - The PROACT II study demonstrated a significant benefit from treatment with intra-arterial pro-urokinase (r-proUK) in patients with middle cerebral artery occlusion treated within 6 hours of stroke onset. The purpose of the current study was to examine baseline factors to determine predictors of good outcome and response to treatment. Methods - We selected from the baseline clinical, radiologic, and angiographic data variables that considered possibly related to outcome. A univariate analysis was performed to examine the association between these baseline factors and good outcome, defined as a modified Rankin scale score ≤2. A multivariate model then selected the most important variables independently influencing prognosis. A risk score for each patient was constructed on the basis of the patient's individual values for each independent variable. Patients were stratified into risk quartiles based on their risk scores, and an odds ratio for each risk quartile was calculated. The treatment effects of each quartile were compared. Results - In the univariate analysis, screening National Institutes of Health stroke scale (NIHSS) score and age were strongly associated with good outcome. The multivariate model selected age, NIHSS score, and CT hypodensity as the most important prognostic variables. Dividing patients into quartiles based on risk scores achieved a uniform gradient of probability of good outcomes. A trend toward benefit of r-proUK treatment was seen in all risk quartiles, and no differential treatment effect was observed across risk groups. Conclusions - There was no evidence of differential effect of r-proUK across subgroups of patients stratified by risk.",
keywords = "Outcome, Stroke, acute, Thrombolytic therapy",
author = "Wechsler, {Lawrence R.} and Robin Roberts and Furlan, {Anthony J.} and Higashida, {Randall T.} and William Dillon and Heidi Roberts and Rowley, {Howard A.} and Pettigrew, {L. Creed} and Callahan, {Alfred S.} and Askiel Bruno and Pierre Fayad and Smith, {Wade S.} and Firszt, {Carolyn M.} and Schulz, {Gregory A.}",
year = "2003",
month = "5",
day = "1",
doi = "10.1161/01.STR.0000068782.15297.28",
language = "English (US)",
volume = "34",
pages = "1224--1229",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Factors influencing outcome and treatment effect in PROACT II

AU - Wechsler, Lawrence R.

AU - Roberts, Robin

AU - Furlan, Anthony J.

AU - Higashida, Randall T.

AU - Dillon, William

AU - Roberts, Heidi

AU - Rowley, Howard A.

AU - Pettigrew, L. Creed

AU - Callahan, Alfred S.

AU - Bruno, Askiel

AU - Fayad, Pierre

AU - Smith, Wade S.

AU - Firszt, Carolyn M.

AU - Schulz, Gregory A.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Background and Purpose - The PROACT II study demonstrated a significant benefit from treatment with intra-arterial pro-urokinase (r-proUK) in patients with middle cerebral artery occlusion treated within 6 hours of stroke onset. The purpose of the current study was to examine baseline factors to determine predictors of good outcome and response to treatment. Methods - We selected from the baseline clinical, radiologic, and angiographic data variables that considered possibly related to outcome. A univariate analysis was performed to examine the association between these baseline factors and good outcome, defined as a modified Rankin scale score ≤2. A multivariate model then selected the most important variables independently influencing prognosis. A risk score for each patient was constructed on the basis of the patient's individual values for each independent variable. Patients were stratified into risk quartiles based on their risk scores, and an odds ratio for each risk quartile was calculated. The treatment effects of each quartile were compared. Results - In the univariate analysis, screening National Institutes of Health stroke scale (NIHSS) score and age were strongly associated with good outcome. The multivariate model selected age, NIHSS score, and CT hypodensity as the most important prognostic variables. Dividing patients into quartiles based on risk scores achieved a uniform gradient of probability of good outcomes. A trend toward benefit of r-proUK treatment was seen in all risk quartiles, and no differential treatment effect was observed across risk groups. Conclusions - There was no evidence of differential effect of r-proUK across subgroups of patients stratified by risk.

AB - Background and Purpose - The PROACT II study demonstrated a significant benefit from treatment with intra-arterial pro-urokinase (r-proUK) in patients with middle cerebral artery occlusion treated within 6 hours of stroke onset. The purpose of the current study was to examine baseline factors to determine predictors of good outcome and response to treatment. Methods - We selected from the baseline clinical, radiologic, and angiographic data variables that considered possibly related to outcome. A univariate analysis was performed to examine the association between these baseline factors and good outcome, defined as a modified Rankin scale score ≤2. A multivariate model then selected the most important variables independently influencing prognosis. A risk score for each patient was constructed on the basis of the patient's individual values for each independent variable. Patients were stratified into risk quartiles based on their risk scores, and an odds ratio for each risk quartile was calculated. The treatment effects of each quartile were compared. Results - In the univariate analysis, screening National Institutes of Health stroke scale (NIHSS) score and age were strongly associated with good outcome. The multivariate model selected age, NIHSS score, and CT hypodensity as the most important prognostic variables. Dividing patients into quartiles based on risk scores achieved a uniform gradient of probability of good outcomes. A trend toward benefit of r-proUK treatment was seen in all risk quartiles, and no differential treatment effect was observed across risk groups. Conclusions - There was no evidence of differential effect of r-proUK across subgroups of patients stratified by risk.

KW - Outcome

KW - Stroke, acute

KW - Thrombolytic therapy

UR - http://www.scopus.com/inward/record.url?scp=0037628968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037628968&partnerID=8YFLogxK

U2 - 10.1161/01.STR.0000068782.15297.28

DO - 10.1161/01.STR.0000068782.15297.28

M3 - Article

VL - 34

SP - 1224

EP - 1229

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 5

ER -